City Research Online

Items where Author is "Fisher, M."

Up a level
Group by: Type | No Grouping
Number of items: 10.

Article

Burch, L. S., Smith, C. J., Anderson, J. , Sherr, L., Rodger, A. J., O'Connell, R., Geretti, A-M., Gilson, R., Fisher, M., Elford, J., Jones, M., Collins, S., Azad, Y., Phillips, A. N., Speakman, A., Johnson, M. A. & Lampe, F. C. (2016). Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses. Lancet Public Health, 1(1), e26-e36. doi: 10.1016/s2468-2667(16)30002-0

Rodger, A. J., Phillips, A. N., Speakman, A. , Gilson, R., Fisher, M., Wilkins, E., Anderson, J., Johnson, M., O'Connell, R., Collins, S., Elford, J., Sherr, L. & Lampe, F. C (2014). Attitudes of People in the UK with HIV Who Are Antiretroviral (ART) Naïve to Starting ART at High CD4 Counts for Potential Health Benefit or to Prevent HIV Transmission. PLoS One, 9(5), article number e97340. doi: 10.1371/journal.pone.0097340

Williams, L. J., Mukherjee, D., Fisher, M. , Reyes-Aldasoro, C. C., Akerman, S., Kanthou, C. & Tozer, G. M. (2014). An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate. British Journal of Pharmacology, 171(21), pp. 4902-4913. doi: 10.1111/bph.12817

Akerman, S., Fisher, M., Daniel, R. A. , Lefley, D. V., Reyes-Aldasoro, C. C., Lunt, S. J., Harris, S., Björndahl, M. A., Williams, L. J., Evans, H., Barber, P. R., Prise, V. E., Vojnovic, B., Kanthou, C. & Tozer, G. M. (2013). Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies. International Journal of Cancer, 133(11), pp. 2563-2576. doi: 10.1002/ijc.28281

Speakman, A., Rodger, A. J., Phillips, A. N. , Gilson, R., Johnson, M., Fisher, M., Edmunds, W. J., Anderson, J., O'Connell, R., Lascar, M., Aderogba, K., Edwards, S., McDonnell, J. V., Perry, N., Sherr, L., Collins, S., Hart, G., Johnson, A. M., Miners, A., Elford, J., Geretti, A-M, Burman, W. J. & Lampe, F. C (2013). The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) Study. Design, Methods and Participant Characteristics. PLoS ONE, 8(10), article number e77230. doi: 10.1371/journal.pone.0077230

Akerman, S., Reyes-Aldasoro, C. C., Fisher, M. , Pettyjohn, K. L., Björndahl, M. A., Evans, H. & Tozer, G. M. (2011). Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agents. Medical Engineering & Physics, 33(7), pp. 805-809. doi: 10.1016/j.medengphy.2010.09.006

Lunt, S. J., Akerman, S., Hill, S. A. , Fisher, M., Wright, V. J., Reyes-Aldasoro, C. C. ORCID: 0000-0002-9466-2018, Tozer, G. M. & Kanthou, C. (2011). Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate. International Journal of Cancer, 129(8), pp. 1979-1989. doi: 10.1002/ijc.25848

Williams, L. J., Fisher, M., Reyes-Aldasoro, C. C. , Kanthou, C. & Tozer, G. M. (2011). Abstract 1578: A critical role for RhoA-GTPase signaling in the tumor vascular disrupting action of combretastatin-A4-phosphate in vivo. Cancer Research, 71(8_Supp), p. 1578. doi: 10.1158/1538-7445.am2011-1578

Conference or Workshop Item

Williams, L. J., Fisher, M., Reyes-Aldasoro, C. C. , Kanthou, C. & Tozer, G. M. (2010). A critical role for RhoA-GTPase signaling in the tumour vascular disrupting action of combretastatin A4-phosphate in vivo. In: http://conference.ncri.org.uk/abstracts/2010/abstracts/C28.htm. 2010 NCRI Cancer Conference, 31-10-2010 - 03-11-2010, Liverpool, UK.

Akerman, S., Reyes-Aldasoro, C. C., Fisher, M. , Pettyjohn, K. L., Björndahl, M. A., Evans, H. & Tozer, G. M. (2009). Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to VEGF-R tyrosine kinase inhibition. Paper presented at the 2nd Micro and Nano Flows Conference (MNF2009), 01-09-2009 - 02-09-2009, London, Uk.

This list was generated on Wed Feb 28 05:11:49 2024 UTC.